Search results
Regeneron Reverses On Better-Than-Feared Eylea Sales
Investor's Business Daily· 6 days agoHigh-dose Eylea came in at $200 million, beating expectations for $189 million, Leerink Partners analyst David Risinger said in a report. The high dose...
Most RA Patients Meet EMA's JAK Inhibitor Warning Criteria
Medscape· 6 days agoRecent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK...
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
FOX21 Colorado Springs· 1 day ago...neoadjuvant UM Phase 2 investigator-sponsored trial on June 3rd, and targeting neoadjuvant UM update in over 30 patients from Phase 2 company-sponsored trial and regulatory guidance both in H2 2024Selected move-forward Phase 2 dose for IDE397 in MTAP squamous NSCLC, based on clinical efficacy...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 2 days agoValneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates Q1 financial highlights Total revenues of €32.8 million, including sales of €32.1 million, on track to meet anticipated full year guidance
High Response Rates With Gene Therapies for BCG-Unresponsive Bladder Cancer
MedPage Today· 5 days agoThree-fourths of patients had complete responses, which proved to be durable in most cases
Earnings call: Cardiff Oncology reports on CRDF-004 trial progress By Investing.com
Investing.com· 5 days agoCardiff Oncology, a biopharmaceutical company focused on developing new treatments for cancer, has...
Earnings call: Cardiff Oncology reports on CRDF-004 trial progress
Investing.com· 6 days agoCardiff Oncology, a biopharmaceutical company focused on developing new treatments for cancer, has...
Q1 2024 Innovid Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 17 hours agoAs I mentioned earlier, we have a roadmap of Harmony products that will continue to be released throughout 2024. We believe Harmony will better balance the...
'Pandemic proof' vaccine could beat coronaviruses we don't even know about yet
The US Sun· 2 days agoBRITISH scientists reckon they can make a vaccine for coronaviruses we do not even know about yet....
EXPLAINER: Boosters key to fight omicron, lot still to learn
AOL· 6 days ago“Everything is riskier now because omicron is so much more contagious,” said Dr. S. Wesley Long, who...
